Penumbra Company Profile (NYSE:PEN)

About Penumbra (NYSE:PEN)

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. It focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Neuro Thrombectomy (Ischemic Stroke), Neurovascular Embolization (Brain Aneurysms) and Neurosurgical Tools (Hemorrhagic Stroke). Its peripheral vascular products include Peripheral Vascular Embolization and Peripheral Thrombectomy.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Equipment
Sub-Industry: N/A
Symbol: NYSE:PEN
CUSIP: N/A
Web: www.penumbrainc.com

Capitalization:

Market Cap: $3.00233 billion
Outstanding Shares: 33,772,000

Average Prices:

50 Day Moving Avg: $85.75
200 Day Moving Avg: $84.49
52 Week Range: $56.05 - $91.00

P/E:

Trailing P/E Ratio: 600.68
Foreward P/E Ratio: 1,270.00
P/E Growth: -65.93

Sales & Book Value:

Annual Revenue: $294.09 million
Price / Sales: 10.21
Book Value: $11.04 per share
Price / Book: 8.05

Profitability:

EBIDTA: ($3,320,000.00)
Net Margins: -2.78%
Return on Equity: -2.58%
Return on Assets: -2.27%

Debt:

Current Ratio: 9.72%
Quick Ratio: 7.56%

Misc:

Average Volume: 150,911 shs.
Beta: 0.09
Short Ratio: 17.55

Frequently Asked Questions for Penumbra (NYSE:PEN)

What is Penumbra's stock symbol?

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

How were Penumbra's earnings last quarter?

Penumbra, Inc. (NYSE:PEN) issued its quarterly earnings results on Tuesday, August, 8th. The company reported ($0.05) EPS for the quarter, meeting analysts' consensus estimates of ($0.05). The company had revenue of $80.60 million for the quarter, compared to analyst estimates of $77.16 million. Penumbra had a negative return on equity of 2.58% and a negative net margin of 2.78%. The company's quarterly revenue was up 23.8% compared to the same quarter last year. During the same period last year, the company earned $0.01 earnings per share. View Penumbra's Earnings History.

Where is Penumbra's stock going? Where will Penumbra's stock price be in 2017?

2 brokers have issued 1-year target prices for Penumbra's shares. Their forecasts range from $96.00 to $100.00. On average, they expect Penumbra's stock price to reach $98.00 in the next year. View Analyst Ratings for Penumbra.

Who are some of Penumbra's key competitors?

Some companies that are related to Penumbra include ICON PLC (ICLR), bluebird bio (BLUE), Exact Sciences Corporation (EXAS), Envision Healthcare Corporation (EVHC), INC Research Holdings (INCR), Neurocrine Biosciences (NBIX), Galapagos NV (GLPG), Juno Therapeutics (JUNO), Charles River Laboratories International (CRL), United Therapeutics Corporation (UTHR), athenahealth (ATHN), Valeant Pharmaceuticals International (VRX), Hill-Rom Holdings (HRC), PRA Health Sciences (PRAH), ACADIA Pharmaceuticals (ACAD), Bio-Techne Corp (TECH), PAREXEL International Corporation (PRXL) and Medidata Solutions (MDSO).

Who are Penumbra's key executives?

Penumbra's management team includes the folowing people:

Adam Elsesser, Chairman of the Board, President, Chief Executive Officer
Sridhar Kosaraju, Chief Financial Officer and Head of Strategy
Daniel Donen Davis, President, North America
James Pray, President, International
Robert D. Evans, Executive Vice President, General Counsel, Secretary
Lynn Rothman, Executive Vice President and Chief Business Officer
Arani Bose M.D., Executive Director and Chief Innovator
Harpreet S. Grewal, Independent Director
Don W. Kassing, Presiding Independent Director
Bridget O'Rourke, Independent Director

Who owns Penumbra stock?

Penumbra's stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (15.00%), Vanguard Group Inc. (6.44%), BlackRock Inc. (5.40%), Alliancebernstein L.P. (3.28%), Lord Abbett & CO. LLC (3.24%) and Redmile Group LLC (2.76%). Company insiders that own Penumbra stock include Adam Elsesser, Arani Bose, Daniel Donen Davis, Don W Kassing, Harpreet Grewal, James Robert Pray, Lynn Rothman, Robert D Evans, Sridhar Kosaraju and Thomas Wilder. View Institutional Ownership Trends for Penumbra.

Who sold Penumbra stock? Who is selling Penumbra stock?

Penumbra's stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Redmile Group LLC, Federated Investors Inc. PA, Marshall Wace North America L.P., Balasa Dinverno & Foltz LLC, Carret Asset Management LLC, Oak Ridge Investments LLC and Pacad Investment Ltd.. Company insiders that have sold Penumbra stock in the last year include Adam Elsesser, Arani Bose, Daniel Donen Davis, Don W Kassing, Harpreet Grewal, James Robert Pray, Lynn Rothman, Robert D Evans, Sridhar Kosaraju and Thomas Wilder. View Insider Buying and Selling for Penumbra.

Who bought Penumbra stock? Who is buying Penumbra stock?

Penumbra's stock was purchased by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., American Century Companies Inc., Russell Investments Group Ltd., BlackRock Inc., State Street Corp, Kennedy Capital Management Inc., Stephens Investment Management Group LLC and Eaton Vance Management. View Insider Buying and Selling for Penumbra.

How do I buy Penumbra stock?

Shares of Penumbra can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Penumbra's stock price today?

One share of Penumbra stock can currently be purchased for approximately $88.90.

MarketBeat Community Rating for Penumbra (NYSE PEN)

Community Ranking:		3.3 out of 5 ( )
Outperform Votes:		104 (Vote Outperform)
Underperform Votes:		52 (Vote Underperform)
Total Votes:		156

MarketBeat's community ratings are surveys of what our community members think about Penumbra and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Penumbra (NYSE:PEN) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	2 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$98.00 (10.24% upside)

Analysts' Ratings History for Penumbra (NYSE:PEN)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
8/9/2017	Canaccord Genuity	Reiterated Rating	Buy	$94.00 -> $100.00	High
6/16/2017	BMO Capital Markets	Reiterated Rating	Buy	$96.00	Low
3/14/2016	Wells Fargo & Company	Reiterated Rating	Outperform		N/A
10/13/2015	Bank of America Corporation	Initiated Coverage	Buy -> Buy	$46.00 -> $46.00	N/A
10/13/2015	J P Morgan Chase & Co	Initiated Coverage	Overweight	$46.00	N/A

(Data available from 9/25/2015 forward)

Earnings History for Penumbra (NYSE:PEN)

Earnings by Quarter for Penumbra (NYSE:PEN)

Earnings History by Quarter for Penumbra (NYSE PEN)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/8/2017	Q2 2017	($0.05)	($0.05)	$77.16 million	$80.60 million	View	Listen
5/9/2017	Q1 2017	($0.06)	($0.10)	$71.08 million	$73.21 million	View	Listen
2/28/2017	Q416	($0.09)	($0.08)	$67.54 million	$73.10 million	View	Listen
11/3/2016	Q316	($0.08)	($0.04)	$63.25 million	$67.20 million	View	N/A
8/9/2016	Q216	($0.07)	$0.01	$58.18 million	$65.10 million	View	N/A
5/9/2016	Q116	($0.07)	$0.02	$53.10 million	$57.90 million	View	N/A
3/8/2016	Q415	($0.10)	$0.05	$46.76 million	$54.40 million	View	N/A
11/12/2015	Q315	($0.15)	$0.03	$43.00 million	$50.42 million	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Penumbra (NYSE:PEN)

Current Year EPS Consensus Estimate: $-0.23 EPS
Next Year EPS Consensus Estimate: $0.07 EPS

Dividend History for Penumbra (NYSE:PEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading and Institutional Ownership History for Penumbra (NYSE:PEN)

Insider Ownership Percentage: 22.00%
Institutional Ownership Percentage: 70.93%

Institutional Ownership by Quarter for Penumbra (NYSE:PEN)

Insider Trades by Quarter for Penumbra (NYSE:PEN)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/21/2017	Robert D Evans	EVP	Sell	4,983	$90.00	$448,470.00
9/20/2017	Robert D Evans	EVP	Sell	2,859	$90.00	$257,310.00
8/21/2017	Harpreet Grewal	Director	Sell	4,500	$82.65	$371,925.00
8/9/2017	Robert D Evans	EVP	Sell	10,000	$85.15	$851,500.00
8/1/2017	Daniel Donen Davis	Insider	Sell	32,000	$79.42	$2,541,440.00
7/18/2017	Thomas Wilder	Director	Sell	345	$86.10	$29,704.50
4/24/2017	Robert D Evans	EVP	Sell	10,000	$85.24	$852,400.00
2/14/2017	Robert D Evans	EVP	Sell	5,000	$75.00	$375,000.00
2/13/2017	Adam Elsesser	CEO	Sell	7,700	$72.21	$556,017.00
2/13/2017	James Robert Pray	Insider	Sell	1,700	$73.04	$124,168.00
2/13/2017	Sridhar Kosaraju	CFO	Sell	1,600	$72.94	$116,704.00
2/10/2017	James Robert Pray	Insider	Sell	23,900	$71.08	$1,698,812.00
2/10/2017	Sridhar Kosaraju	CFO	Sell	15,500	$71.49	$1,108,095.00
2/9/2017	Arani Bose	Insider	Sell	22,300	$70.44	$1,570,812.00
2/9/2017	Lynn Rothman	EVP	Sell	2,700	$70.20	$189,540.00
2/7/2017	James Robert Pray	Insider	Sell	4,099	$69.09	$283,199.91
2/7/2017	Robert D Evans	EVP	Sell	1	$70.00	$70.00
2/6/2017	Arani Bose	Insider	Sell	17,100	$70.01	$1,197,171.00
2/6/2017	Lynn Rothman	EVP	Sell	2,886	$70.41	$203,203.26
2/6/2017	Sridhar Kosaraju	CFO	Sell	100	$70.00	$7,000.00
2/3/2017	James Robert Pray	Insider	Sell	15,600	$70.39	$1,098,084.00
2/3/2017	Robert D Evans	EVP	Sell	5,000	$70.35	$351,750.00
2/3/2017	Sridhar Kosaraju	CFO	Sell	7,800	$70.56	$550,368.00
2/1/2017	Adam Elsesser	CEO	Sell	21,400	$70.98	$1,518,972.00
2/1/2017	Daniel Donen Davis	Insider	Sell	7,298	$71.00	$518,158.00
2/1/2017	Lynn Rothman	EVP	Sell	4,414	$70.99	$313,349.86
1/31/2017	Adam Elsesser	CEO	Sell	9,000	$71.26	$641,340.00
1/31/2017	Daniel Donen Davis	Insider	Sell	3,000	$71.29	$213,870.00
1/31/2017	Lynn Rothman	EVP	Sell	1,800	$71.27	$128,286.00
1/30/2017	Adam Elsesser	CEO	Sell	8,200	$70.72	$579,904.00
1/30/2017	Daniel Donen Davis	Insider	Sell	2,698	$70.71	$190,775.58
1/30/2017	Lynn Rothman	EVP	Sell	1,700	$70.79	$120,343.00
1/27/2017	Arani Bose	Insider	Sell	31,500	$74.12	$2,334,780.00
1/27/2017	Lynn Rothman	EVP	Sell	7,000	$74.24	$519,680.00
1/26/2017	Don W Kassing	Director	Sell	3,000	$74.50	$223,500.00
11/16/2016	Sridhar Kosaraju	CFO	Sell	25,000	$65.07	$1,626,750.00
9/9/2016	Adam Elsesser	CEO	Sell	57,200	$71.07	$4,065,204.00
9/6/2016	Arani Bose	Insider	Sell	61,000	$70.72	$4,313,920.00
9/2/2016	Robert D Evans	EVP	Sell	3,100	$70.10	$217,310.00
8/31/2016	Adam Elsesser	CEO	Sell	26,000	$71.15	$1,849,900.00
8/31/2016	Robert D Evans	EVP	Sell	5,300	$71.17	$377,201.00
8/26/2016	Adam Elsesser	CEO	Sell	26,800	$71.06	$1,904,408.00
8/26/2016	Robert D Evans	EVP	Sell	5,300	$71.03	$376,459.00
8/24/2016	Adam Elsesser	CEO	Sell	29,000	$72.95	$2,115,550.00
8/24/2016	Robert D Evans	EVP	Sell	6,300	$73.00	$459,900.00
5/23/2016	Robert D Evans	EVP	Sell	5,000	$50.52	$252,600.00
5/19/2016	Don W Kassing	Director	Sell	3,000	$48.63	$145,890.00
5/19/2016	Robert D Evans	EVP	Buy	1,538	$25.50	$39,219.00
5/16/2016	James Robert Pray	Insider	Sell	32,500	$48.51	$1,576,575.00

(Data available from 1/1/2013 forward)

Headline Trends for Penumbra (NYSE:PEN) Latest Headlines for Penumbra (NYSE:PEN)

Source:

Date	Headline
	Penumbra, Inc. (PEN) EVP Sells $257,310.00 in Stock www.americanbankingnews.com - September 22 at 7:52 PM
	Penumbra, Inc. (PEN) EVP Sells $448,470.00 in Stock www.americanbankingnews.com - September 22 at 7:52 PM
	$79.13 Million in Sales Expected for Penumbra Inc (PEN) This Quarter www.americanbankingnews.com - September 12 at 1:16 PM
	Penumbra, Inc. breached its 50 day moving average in a Bullish Manner : PEN-US : September 4, 2017 finance.yahoo.com - September 4 at 8:44 PM
	Penumbra, Inc. (PEN) Given $91.60 Consensus Target Price by Brokerages www.americanbankingnews.com - September 2 at 9:06 AM
	Penumbra, Inc. (PEN) Upgraded to "Hold" at Zacks Investment Research www.americanbankingnews.com - August 30 at 11:50 PM
	Penumbra Earns Relative Strength Rating Upgrade; Hits Key Benchmark finance.yahoo.com - August 30 at 7:51 AM
	Penumbra, Inc. Announces Participation at Upcoming Investor Conferences finance.yahoo.com - August 25 at 9:57 AM
	Penumbra, Inc. breached its 50 day moving average in a Bullish Manner : PEN-US : August 24, 2017 finance.yahoo.com - August 24 at 10:58 AM
	Penumbra, Inc. (PEN) Director Harpreet Grewal Sells 4,500 Shares www.americanbankingnews.com - August 23 at 7:46 PM
	Penumbra, Inc. (PEN) Short Interest Down 1.4% in July www.americanbankingnews.com - August 22 at 11:10 PM
	Zacks: Brokerages Expect Penumbra, Inc. (PEN) Will Post Earnings of -$0.07 Per Share www.americanbankingnews.com - August 22 at 4:14 PM
	Penumbra, Inc. (PEN) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - August 20 at 7:06 AM
	See what the IHS Markit Score report has to say about Penumbra Inc. finance.yahoo.com - August 13 at 2:38 AM
	Penumbra, Inc. (NYSE:PEN) Rating Lowered to Sell at Zacks Investment Research www.americanbankingnews.com - August 12 at 7:02 PM
	Penumbra, Inc. (PEN) Upgraded by BidaskClub to Buy www.americanbankingnews.com - August 12 at 10:00 AM
	Robert D. Evans Sells 10,000 Shares of Penumbra, Inc. (PEN) Stock www.americanbankingnews.com - August 11 at 7:52 PM
	Penumbra, Inc. breached its 50 day moving average in a Bullish Manner : PEN-US : August 10, 2017 finance.yahoo.com - August 11 at 7:30 AM
	Penumbra, Inc. breached its 50 day moving average in a Bullish Manner : PEN-US : August 10, 2017 finance.yahoo.com - August 11 at 7:30 AM
	IHS Markit Score upgrades Penumbra Inc to 47 out of 100, despite ranking positively in only one IHS Markit category. finance.yahoo.com - August 10 at 6:43 AM
	Edited Transcript of PEN earnings conference call or presentation 8-Aug-17 8:30pm GMT finance.yahoo.com - August 10 at 6:43 AM
	Penumbra, Inc. (NYSE:PEN) Posts Quarterly Earnings Results, Hits Estimates www.americanbankingnews.com - August 9 at 11:38 PM
	Penumbra, Inc. (NYSE:PEN) Given Consensus Rating of "Strong Buy" by Brokerages www.americanbankingnews.com - August 9 at 6:48 PM
	Penumbra, Inc. (PEN) Stock Rating Reaffirmed by Canaccord Genuity www.americanbankingnews.com - August 9 at 9:00 AM
	Investor Network: Penumbra, Inc. to Host Earnings Call finance.yahoo.com - August 9 at 6:19 AM
	Penumbra, Inc. Reports Second Quarter 2017 Financial Results finance.yahoo.com - August 9 at 6:19 AM
	Penumbra reports 2Q loss finance.yahoo.com - August 9 at 6:19 AM
	Penumbra, Inc. (PEN) Expected to Announce Quarterly Sales of $77.99 Million www.americanbankingnews.com - August 6 at 7:54 AM
	Penumbra, Inc. (NYSE:PEN) Lowered to Sell at BidaskClub www.americanbankingnews.com - August 5 at 12:56 PM
	-$0.05 Earnings Per Share Expected for Penumbra, Inc. (PEN) This Quarter www.americanbankingnews.com - August 4 at 10:28 AM
	Daniel Donen Davis Sells 32,000 Shares of Penumbra, Inc. (NYSE:PEN) Stock www.americanbankingnews.com - August 3 at 7:32 PM
	Is a Surprise in Store for Penumbra (PEN) in Q2 Earnings? finance.yahoo.com - August 3 at 6:48 AM
	Penumbra, Inc. – Value Analysis (NYSE:PEN) : July 31, 2017 finance.yahoo.com - August 1 at 1:59 AM
	Penumbra, Inc. breached its 50 day moving average in a Bullish Manner : PEN-US : July 26, 2017 finance.yahoo.com - July 27 at 6:18 AM
	Penumbra, Inc. Schedules Second Quarter 2017 Earnings Release and Conference Call for August 8, 2017 at 4:30 PM Eastern Time finance.yahoo.com - July 26 at 6:19 AM
	Penumbra, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference finance.yahoo.com - July 26 at 6:19 AM
	Brokerages Anticipate Penumbra, Inc. (NYSE:PEN) to Announce ($0.05) EPS www.americanbankingnews.com - July 25 at 9:59 AM
	Tactile Systems Technology (TCMD) & Penumbra (NYSE:PEN) Financial Analysis www.americanbankingnews.com - July 25 at 8:43 AM
	Contrasting Entellus Medical (ENTL) and Penumbra (NYSE:PEN) www.americanbankingnews.com - July 23 at 7:51 AM
	ETFs with exposure to Penumbra, Inc. : July 21, 2017 finance.yahoo.com - July 22 at 7:31 AM
	Penumbra, Inc. (PEN) Director Sells $29,704.50 in Stock www.americanbankingnews.com - July 20 at 10:24 PM
	$77.99 Million in Sales Expected for Penumbra, Inc. (NYSE:PEN) This Quarter www.americanbankingnews.com - July 15 at 9:44 AM
	Penumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : July 14, 2017 finance.yahoo.com - July 15 at 7:24 AM
	Penumbra, Inc. (NYSE:PEN) Given $89.00 Consensus Price Target by Brokerages www.americanbankingnews.com - July 15 at 12:44 AM
	Brokerages Anticipate Penumbra, Inc. (PEN) Will Post Earnings of -$0.05 Per Share www.americanbankingnews.com - July 13 at 8:13 AM
	ETFs with exposure to Penumbra, Inc. : July 10, 2017 finance.yahoo.com - July 11 at 6:33 AM
	Critical Comparison: Tactile Systems Technology (TCMD) & Penumbra (PEN) www.americanbankingnews.com - July 6 at 7:40 AM
	Brokerages Expect Penumbra, Inc. (PEN) to Post ($0.05) EPS www.americanbankingnews.com - June 29 at 12:42 AM
	Penumbra, Inc. breached its 50 day moving average in a Bearish Manner : PEN-US : June 28, 2017 finance.yahoo.com - June 28 at 4:19 PM
	Penumbra (PEN) at 52-Week High: What's Driving the Stock? www.zacks.com - June 28 at 12:18 AM

Penumbra (PEN) Chart for Monday, September, 25, 2017

This page was last updated on 9/25/2017 by MarketBeat.com Staff

Penumbra Company Profile (NYSE:PEN)

About Penumbra (NYSE:PEN)

What is Penumbra's stock symbol?

How were Penumbra's earnings last quarter?

Where is Penumbra's stock going? Where will Penumbra's stock price be in 2017?

Who are some of Penumbra's key competitors?

Who are Penumbra's key executives?

Who owns Penumbra stock?

Who sold Penumbra stock? Who is selling Penumbra stock?

Who bought Penumbra stock? Who is buying Penumbra stock?

How do I buy Penumbra stock?

What is Penumbra's stock price today?

Analyst Ratings

Earnings

Estimates

Dividends

Insider Trades

Headlines

Social

Chart